You searched for "AMM"
Topcon & OcuPlan: Importance of early AMD diagnosis and how to communicate with patients free interactive CPD session evening event (Worcestershire)
29 June 2023
Join us for an interactive CPD session on the importance of early AMD diagnosis and how to communicate with patients. We are teaming up with Topcon to run 5 evening events over May, June and July. The two-part sessions will...
Topcon & OcuPlan: Importance of early AMD diagnosis and how to communicate with patients free interactive CPD session evening event (Leicestershire)
3 July 2023
Join us for an interactive CPD session on the importance of early AMD diagnosis and how to communicate with patients. We are teaming up with Topcon to run 5 evening events over May, June and July. The two-part sessions will...
Topcon & OcuPlan: Importance of early AMD diagnosis and how to communicate with patients free interactive CPD session evening event (Nottinghamshire)
27 June 2023
Join us for an interactive CPD session on the importance of early AMD diagnosis and how to communicate with patients. We are teaming up with Topcon to run 5 evening events over May, June and July. The two-part sessions will...
More sensitive visual acuity test for age-related macular degeneration
1 October 2016
| Roger S Anderson (Prof), Nilpa Shah
|
EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. Primarily associated with ageing, genetic factors and lifestyle choices such as smoking also play a contributory role. Patients with early AMD, characterised by the development of...
Quiz Aug/Sep 2022
2 August 2022
|
EYE - General
History A 58-year-old female patient was referred with a 2-year history, gradually enlarging, painless left upper lid lump. There was no bleeding or ulceration. She had no other eye symptoms and no other skin lesions. Her past medical history included:...
AAO cancels meeting for first time since 1945
23 July 2020
The AAO has announced that its 2020 meeting will now be virtual only.
Computerised visual acuity measurements in AMD
1 December 2015
| Nana Theodorou
|
EYE - Vitreo-Retinal
The aims of this study were to investigate whether half-letter width spacing in COMPlog algorithms had an adverse effect on agreement in patients with AMD with the ETDRS chart. Fifty adult participants with AMD took part with a median age...
Complement factor B polymorphism and the phenotype of early age-related macular degeneration
1 August 2014
| Huw Edward Oliphant
|
EYE - Vitreo-Retinal
The relationship between complement factor H (CFH) and age-related macular degeneration (AMD) is very well known, but other genetic polymorphisms relating to AMD are more poorly understood. This study was designed to investigate the relationship between complement factor B (CFB)...
Complement Factor H and Factor H-Like protein are expressed in human RPE cells
1 April 2014
| Bheemanagouda Patil
|
EYE - General
The role of inflammation in age-related macular degeneration (AMD) is well documented and the association of AMD with the inflammatory marker C-reactive protein (CRP) and members of the complement system underline the role of complements in AMD. Human complement factor...
The rarebit vision test for macular conditions
1 October 2015
| Nana Theodorou
|
EYE - Vitreo-Retinal
Rarebit testing is used to measure low degrees of neuro-visual damage and is available for free on the internet. It consists of a fixed bright light dot presented on a black background. During testing it is presented briefly at different...
HtrA1 enhances cell senescence
1 December 2013
| Graham Wallace
|
EYE - Vitreo-Retinal
A genetic basis for age-related macular degeneration (AMD) has been greatly advanced in recent years. The role of identified pathways such as complement factor H in AMD has been widely investigated. However, the effect of other gene variants identified by...
Ranibizumab for the treatment of age-related macular degeneration
1 April 2015
| Nana Theodorou
|
EYE - Vitreo-Retinal
This multicentre randomised prospective open label study compared 0.5 versus 2mg of ranibizumab in patients with submacular retinal pigment epithelial (RPE) detachment due to age-related macular degeneration. Four treatment regimens were used for the two strengths either monthly for 12...
